Medical Xpress·3 min read·hard
Novel blood-based biomarker enables early lung cancer detection and prognosis prediction
K
Korea University College of Medicine
✦AI Summary
Researchers have identified a blood-based biomarker using GCC2 protein in extracellular vesicles to detect early-stage lung adenocarcinoma. This discovery offers a potential alternative to invasive biopsies for improved prognosis and treatment.
edited by Gaby Clark , reviewed by Andrew Zinin
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in